Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Inscinstech develops and manufactures advanced biological separation equipment and chemical analysis instruments. Its product line includes automated oligonucleotide synthesizers for DNA/RNA/mRNA drug development, FPLC protein purification systems for biopharmaceuticals such as monoclonal antibodies and recombinant proteins, crossflow filtration systems for sample processing, and nanoparticle assembly platforms widely used in mRNA drug production. The company holds numerous patents/copyrights and serves global customers with R&D centers in Suzhou, China and Los Angeles. No clinical results as it does not develop therapeutics directly.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Inscinstech Co., Ltd..